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Summary
Klinefelter syndrome (KS) is a chromosomal disorder affecting males, with the typical karyotype of 47,XXY due to 
a supernumerary X chromosome, which causes progressive testicular failure resulting in androgen deficiency and 
infertility. Despite it being the most common sex chromosomal disorder, its diagnosis is easily missed. In addition to its 
classical clinical features of tall stature, gynaecomastia, small testes, and symptoms and signs of hypogonadism including 
infertility, KS is also often associated with neurocognitive, behavioural and psychiatric disorders.
We present a 44-year-old man with KS who, despite having erectile dysfunction, paradoxically had increased libido. 
He used sildenafil to overcome his erectile dysfunction. Hypersexuality was manifested by very frequent masturbation, 
multiple sexual partners most of whom were casual, and a sexual offence conviction at the age of 17 years.
Discussion focuses on the frequent failure of clinicians to diagnose KS, the neurocognitive, behavioural and 
psychiatric aspects of KS, this unusual presentation of hypersexuality in a man with KS, and the challenges of medical 
management of hypogonadism in a man with a history of a sexual offence.
Background
Klinefelter Syndrome (KS) is the commonest chromosomal 
disorder in males and the commonest cause of male 
hypogonadism. It affects about 1 in 600 men, however 
the majority remain undiagnosed (1, 2). Classically, 
it is defined by the 47,XXY karyotype, but variants 
exist (e.g. mosaics; 48,XXXY; 49,XXXY). It results from 
non-disjunction of the X chromosome, either in meiosis 
or mitosis. When it occurs in mitosis post-fertilization, a 
mosaic form (46,XY/47,XXY) can occur accounting for 
about 10% of cases (1, 2).
KS boys enter puberty at the expected age with an 
appropriate initial rise in testosterone concentrations, 
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Learning points:
 • Klinefelter syndrome (KS) is common in men (about 1 in 600 males), but the diagnosis is very often missed.
 • In addition to classic features of hypogonadism, patients with KS can often have associated neurocognitive, 
behavioural and/or psychiatric disorders.
 • More awareness of the association between KS and difficulties related to verbal skills in boys could improve rates 
of early diagnosis and prevent longer-term psychosocial disability.
 • Hypersexuality in the context of hypogonadism raises the possibility of sex steroid independent mechanistic 
pathways for libido.
 • Testosterone replacement therapy in KS with hypersexuality should be undertaken with caution using a 
multidisciplinary team approach.
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but they fall by mid-puberty and hypergonadotrophic 
hypogonadism evolves. Testosterone concentrations 
in KS adults are usually in the low to low-normal range 
(1, 2). Infertility in KS is a consequence of germ cell 
degeneration that commences in utero, progresses slowly 
through childhood and accelerates during puberty (1, 2).
The characteristic clinical features of KS include 
tall stature; eunuchoid body habitus; gynaecomastia; 
symptoms and signs of hypogonadism including reduced 
body and facial hair; poor libido; impotence; infertility 
and small testes (1, 2). Concurrent cognitive, behavioural 
and/or psychiatric disorders can be present and in some 
cases be the presenting feature (1, 2, 3). For example, boys 
with KS can present with learning difficulties, particularly 
due to delayed development of verbal skills, and/or 
with behavioural issues. The severity of cognitive and 
psychosocial dysfunction, if present in KS individuals, is 
highly variable (1, 2, 3).
This case is of a man with a late diagnosis of KS, who 
had a history of learning and behavioural difficulties in 
his early years, and the unusual problem of increased 
rather than reduced libido.
Case presentation
A 44-year-old man, employed as a supermarket check-
out operator, presented in 2014 with a long-term history 
of erectile dysfunction, lethargy, low mood and poor 
concentration. Because of daytime tiredness, he would 
often nap. He was not shaving regularly. Unexpectedly, 
he described markedly increased libido characterized 
by uncontrollable urges to masturbate and the need for 
frequent heterosexual encounters. With a partner, he had 
problems with erections and ejaculation, but reported 
benefit with the cGMP-specific phosphodiesterase type 5 
inhibitor, sildenafil.
Other than symptoms of sexual dysfunction and 
low androgenization, he denied endocrine symptoms 
suggestive of pituitary, adrenal or thyroid disease.
His excessive libido had, and was still having, 
detrimental effects on his life. At age 17  years, he was 
convicted of a sexual offence against a minor (a 9 year old 
girl). Although he had been diagnosed a ‘closet paedophile’ 
by a psychologist, he denied any fantasies or urges to have 
sexual contact with children. From 20  years of age, he 
claimed that he had sex with more than 1800 partners, 
the majority (>95%) being sex workers. He was attending 
regularly for sexually transmitted infection screening 
(more than 3 times in the last year) and had been treated 
for genital warts with imiquimod cream multiple times. 
He believed that he was afflicted by ‘sexual addiction,’ 
being unable to control his desires and behaviours.
He had a history of learning and behavioural 
difficulties. He stated that he used to play alone and 
was diagnosed with autism as a child for which he did 
not receive treatment. He had learning difficulties in 
school, particularly with language and more specifically 
comprehension. He started a degree programme in 
pharmacy, but found it very difficult and deferred 
his classes.
His other health problems include obesity, obstructive 
sleep apnoea awaiting continuous positive air pressure 
(CPAP) treatment, gout, intermittent sciatica and asthma. 
His weight had increased from 88 to 110 kg at the age of 
30 years, at which time he stopped competitive dancing 
and exercising. After joining a life style modification 
programme, he managed to lose 10 kg of weight. His 
medications included budesonide/eformoterol Turbuhaler 
200/6 µg/dose twice daily and salbutamol inhaler 100 µg/
dose as a reliever for asthma; pregabalin 300 mg oral daily 
for sciatica; intermittent non-steroidal anti-inflammatory 
agents for gout; and sildenafil orally for impotence.
He was living alone and denied ever having a long-
term partner. He used alcohol only occasionally, but 
denied ever being a smoker or using recreational drugs. 
He denied use of ‘black market’ testosterone preparations. 
He was not aware of a family history of mental illness, 
chromosomal disorders or other endocrine conditions.
On examination, his weight was 100.1 kg, height was 
1.84 m and body mass index was 29.6 kg/m2. His blood 
pressure was 118/70 mmHg sitting and 106/69 mmHg, 
standing. He was centrally obese without an obvious 
eunuchoid body habitus and his muscle bulk was poor. He 
had gynaecomastia and some non-pigmented abdominal 
stretch marks. Body hair was sparse on his face, torso and 
axillae, however pubic hair was present. His testes were 
small (<5 mL). He had a protruding jaw, without orbital 
ridging or spade-like hands, and his visual fields were 
normal. His cardiovascular and respiratory examinations 
were unremarkable.
Investigation
His morning testosterone was reduced at 6.6 nmol/L 
and 6.3 nmol/L on repeat (7.0–31.0) and his luteinizing 
hormone (LH) and follicle-stimulating hormone (FSH) were 
both elevated, 20 U/L (<12) and 40 U/L (<12) respectively, 
consistent with hypergonadotrophic hypogonadism. 
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Sex  hormone binding globulin was 25.1 nmol/L (14.5–
48.4). Levels of prolactin, adrenocorticotropic hormone, 
growth hormone and insulin-like growth factor 1 were 
normal. Free thyroxine (T4) was borderline low on two 
occasions, 9.7 and 9.2 pmol/L (10.7–17.0), but free tri-
iodothyronine (T3) and thyroid-stimulating hormone 
(TSH) levels were in the normal range. MRI of the pituitary 
was normal, such that secondary hypothyroidism or other 
pituitary conditions were thought unlikely.
Cytogenetic examination of 80 cells showed a male 
karyotype with an additional X chromosome (47, XXY) 
in 75 cells, 2 additional X chromosomes (48, XXXY) in 
one cell, and 46, XY in 4 cells. The finding was diagnostic 
of mosaic KS. Fluorescent in situ hybridization (FISH) 
investigation, with probes specific for the centromeric 
regions of chromosomes X, Y and 18, showed signal 
patterns consistent with the 3 cell lines observed in the 
conventional karyotype.
His bone densitometry revealed osteopenia. His intact 
parathyroid hormone level was 8.2 pmol/L (1.6–7.2), but 
his serum calcium and 25-hydroxy-vitamin D3 levels were 
normal. Fasting plasma glucose was 6.2 mmol/L, raising 
the possibility of impaired glucose tolerance. His lipid 
profile was within acceptable limits. Other haematology 
and biochemistry investigations, including renal and liver 
function tests, were normal.
Treatment
It was felt that testosterone therapy was indicated for his 
presenting symptoms of lethargy, low mood and poor 
concentration and for the prevention of osteoporosis; 
however there were obvious concerns for sexual offence 
recidivism. For this reason, a multidisciplinary approach 
was taken involving the patient’s general practitioner, a 
clinical psychologist, an endocrinologist and a forensic 
psychiatrist. The psychologist believed the risk of 
dysfunctional sexual behaviour was low and a decision 
was cautiously made to commence him on a low dose of 
short-acting testosterone therapy. He was commenced 
on testosterone 2% solution (Axiron) topically at a dose 
of 30 mg per day. The usual initial dose is 60 mg per day. 
The patient was given instruction to stop therapy if he 
experienced adverse effects. He returned a few weeks later 
and reported increased mood swings without change 
in libido or sexual function. He was reassured that his 
mood swings may have been caused by the initial rise in 
testosterone levels and he was encouraged to continue 
with therapy. He was switched to a low-dose, short-acting 
testosterone transdermal patch, 2.5 mg daily (Androderm). 
After another 8 weeks, he reported improved mood and 
energy, and the need for more frequent shaving. His 
testosterone was 8.6 nmol/L.
He was eventually assessed by a forensic psychiatrist. 
It was his opinion that the patient did not elicit evidence 
of paraphilia and the risk of him committing another 
sexual offence was low. He concluded that it was safe to 
treat him with testosterone. He did not make an official 
mental health diagnosis. The psychiatrist, however, 
recommended therapy with the selective serotonin 
reuptake inhibitor (SSRI) fluoxetine to improve his mood 
and to utilize its recognized adverse effect of inhibiting 
libido to reduce his hypersexual desire. The patient 
declined fluoxetine, but agreed to ongoing psychotherapy 
with the psychologist.
Discussion
This case illustrates the challenges of KS diagnosis 
and highlights the importance of recognising the 
neurocognitive, behavioural and psychiatric aspects of 
this condition. Hypersexuality in a man with KS is very 
unusual and is discussed in relation to the available 
literature. Also, the challenges of ethical medical 
management of hypogonadism in a man with a history of 
a sexual offense are addressed.
The diagnosis of KS is missed in up to 90% of 
adolescents and 75% of adults (1). Intrauterine diagnosis 
rates are likely increasing with more frequent use of 
prenatal genetic testing, but still only in a minority of 
pregnancies. It is clear that health professional’s increased 
awareness of KS and its clinical features is required. 
Diagnosis in adolescents is difficult, as they usually enter 
puberty at the normal time and it is not until later in 
teenage years that the clinical features of hypogonadism 
and testicular atrophy become evident. A lesson from this 
case is to think of this possibility in boys and adolescents 
who have learning difficulties or display abnormal 
psychosocial characteristics (1, 2).
This patient did emphasize the difficulty he had with 
comprehension at school. In neuropsychological testing 
KS subjects consistently perform poorly in verbal skills 
(1, 2). Behavioural and psychiatric disorders, including 
autism, attention deficit hyperactivity disorder, bipolar 
affective disorders and schizophrenia have been believed 
to be overrepresented in KS individuals; however the 
evidence base indicative of increased major psychiatric 
illness in KS is poor (1, 2, 3, 4, 5). The learning difficulties 
and autism features present early, suggesting that they are 
independent of testosterone deficiency. It is unclear if early 
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testosterone treatment can have an ameliorating effect 
on neurocognitive or behavioural aspects if commenced 
early in puberty (2).
The patient described here displayed anti-social 
behaviour once at the age of 17 and it involved a sexual 
offence involving a minor. Anti-social personality 
disorders resulting in passive-aggressive tendencies, 
criminal behaviours and interestingly paraphilia have 
been linked to KS, but this has been questioned due 
to poor-quality evidence (2, 3, 4, 5). However, KS is a 
condition classically associated with low libido due to 
hypogonadism (6). Hence the hypersexual desire in this 
patient is very unusual. Sinha et al., described a 22-year-
old KS patient with similar issues (7). Hypersexual desires 
in this other man clearly interfered with his social and 
academic functioning, which interestingly was lessened 
by sertraline (an SSRI) therapy (7). Both cases meet Kafka’s 
criteria for hypersexual desire – a pattern of repetitive 
and strong sexual urge, desires and behaviours that lead 
to clinically significant distress, adverse consequences or 
impairment of function (8).
These two cases of high libido on the background of 
hypogonadism point to mechanisms independent of the 
well-known effects of androgens in determining libido. The 
dopamine and acetylcholine signalling pathways within 
the brain may have a role. Hypersexual drive has been 
described as an adverse effect of dopamine agonists used 
for treating Parkinson’s disease and acetylcholinesterase 
inhibitors used in the treatment of dementia (9).
This case raises the ethical issues of prescribing 
testosterone therapy in patients with prior sexual 
convictions. Studer et al. linked sexual offence recidivism 
to testosterone levels. In 501 convicted adult male sex 
offenders, it was found that men with higher testosterone 
levels tended to have committed the most invasive 
sexual crimes and were more likely to re-offend (10). It 
is for these reasons that a multidisciplinary approach 
is necessary, bringing together essential skills of a 
psychologist, psychiatrist and endocrinologist. Although 
testosterone offers benefits of physical well-being, the risk 
of precipitating a vulnerable individual towards criminal 
behaviour must be evaluated at an individual level. 
Careful introduction of testosterone therapy at low doses 
with an easily reversible delivery method, such as the 
topical agents used in this case, is preferable to long-acting 
intramuscular methods (testosterone undeconoate). 
Regular follow-up to ensure treatment is not causing 
adverse effects needs to be included in the management 
plan. It was disappointing that this man declined therapy 
with an SSRI agent.
In conclusion, KS adults have both significant 
physical symptoms of hypogonadism and neurocognitive, 
psychosocial and behavioural problems that should be 
managed together, with multi-disciplinary input. More 
awareness of the condition with increased efforts to 
diagnose it earlier is necessary to improve outcomes.
Declaration of interest
The authors declare that there is no conflict of interest that could be 
perceived as prejudicing the impartiality of this work.
Funding
This work did not receive any specific grant from any funding agency in 
the public, commercial or not-for-profit sector.
Patient consent
A written informed consent has been obtained from the patient, and the 
consent form is attached.
Author contribution statement
Dr Kingsley Okolie is a general practitioner, he was involved in the 
management of the patient and wrote the initial draft of this report. 
Dr Sumathy Perampalam is an endocrinologist, she was involved in the 
management of the patient and contributed to writing this report. Dr 
Anthony Barker is a forensic psychiatrist, he reviewed the patient and 
contributed to writing this report. Prof Christopher Nolan assisted Dr 
Okolie in researching the topic and in writing the report.
References
 1 Groth KA, Skakkebaek A, Host C, Gravholt CH & Bojesen 
A 2013 Clinical review: Klinefelter syndrome – a clinical 
update. Journal of Clinical Endocrinology and Metabolism 98 
20–30. (doi:10.1210/jc.2012-2382)
 2 Bonomi M, Rochira V, Pasquali D, Balercia G, Jannini EA, Ferlin A & 
Klinefelter Italia NG 2017 Klinefelter syndrome (KS): genetics, clinical 
phenotype and hypogonadism. Journal Endocrinolology Investigation 40 
123–134. (doi:10.1007/s40618-016-0541-6)
 3 Hong DS & Reiss AI 2014 Cognitive and neurological aspects 
of sex chromosome aneuploidies. Lancet Neurolology 13 
306–318. (doi:10.1016/S1474-4422(13)70302-8)
 4 Cederlof M, Ohlsson Gotby A, Larsson H, Serlachius E, Boman M, 
Langstrom N, Landen M & Lichtenstein P 2014 Klinefelter syndrome 
and risk of psychosis, autism and ADHD. Journal of Psychiatric Research 
48 128–130. (doi:10.1016/j.jpsychires.2013.10.001)
 5 Annagur BB & Kandeger A 2014 Case of Klinefelter’s syndrome 
in an 18-year-old male presented with antisocial personality 
disorder. Journal of Psychiatry and Neurological Sciences 27 
254–255. (doi:10.5350/dajpn2014270309)
Downloaded from Bioscientifica.com at 06/24/2019 12:57:54AM
via Australian National University, Australian National University and Australian National University
PROOF ONLY
K Okolie and others ID: 17-0082; August 2017
DOI: 10.1530/EDM-17-0082
Hypersexual desire in 
Klinefelter syndrome
http://www.edmcasereports.com 5
 6 Corona G, Petrone L, Paggi F, Lotti F, Boddi V, Fisher A, Vignozzi L, 
Balercia G, Sforza A, Forti G, et al. 2010 Sexual dysfunction in 
subjects with Klinefelter’s syndrome. International Journal of Andrology 
33 574–580.
 7 Sinha P, Jnanaprakasan PP & Andrade C 2012 Hyperactive sexual  
desire in Klinefelter Syndrome: treatment with sertraline. Psychiatry  
and Clinical Neurosciences 66 533. (doi:10.1111/j.1440-1819. 
2012.02375.x)
 8 Kafka MP 2010 Hypersexual disorder: a proposed diagnosis for DSM-V. 
Archives of Sexual Behavior 39 377–400. (doi:10.1007/s10508-009-9574-7)
 9 Segrec N, Zaman R & Pregelj P 2016 Increased libido associated 
with donepezil treatment: a case report. Psychogeriatrics 16 
70–72. (doi:10.1111/psyg.12113)
 10 Studer LH, Aylwin AS & Reddon JR 2005 Testosterone, sexual offense 
recidivism, and treatment effect among adult male sex offenders. Sex 
Abuse 17 171–81. (doi:10.1177/107906320501700207)
Received in final form 22 June 2017
Accepted 10 July 2017
Downloaded from Bioscientifica.com at 06/24/2019 12:57:54AM
via Australian National University, Australian National University and Australian National University
